Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genetic Screening of an At-risk Population for Hereditary TransthyRetin-related AMyloidosis and Longitudinal Monitoring of TTR Positive Subjects- A Multicenter Epidemiological Longitudinal Protocol

NCT03237494 is registered in ClinicalTrials.gov with CENTOGENE GmbH Rostock as lead sponsor.

NCT NCT03237494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03237494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genetic Screening of an At-risk Population for Hereditary TransthyRetin-related AMyloidosis and Longitudinal Monitoring of TTR Positive Subjects- A Multicenter Epidemiological Longitudinal Protocol
Lead sponsor
CENTOGENE GmbH Rostock
Phase
Observational
Overall status
Completed
Start date
July 20, 2017
Completion date
May 16, 2025
Enrollment
5,028 (actual)
Sites
84

Conditions

As the registry lists them; a condition with its own page is linked.

cardiomyopathies, polyneuropathies, transthyretin amyloidosis, transthyretin-related (attr) familial amyloid cardiomyopathy, transthyretin-related (attr) familial amyloid polyneuropathy